Baxter launches campaign to educate Chronic Kidney Disease patients about Peritoneal Dialysis

New Delhi: Baxter India, a global leader in dialysis care, has launched the “Choose Freedom” education campaign to raise awareness of the critical importance of timely dialysis treatment and empower End Stage Kidney Disease (ESKD) patients with an understanding of Peritoneal Dialysis (PD) therapy.

The therapy helps achieve the quadruple aim of better clinical outcomes, allowing patients to maintain their lifestyle and independence, and improving health care professionals’ experiences.

Chronic Kidney Disease (CKD) is a growing epidemic and a rising global public health concern, with 850 million people affected worldwide. As a progressive disease, very often linked to diabetes, CKD can lead to kidney failure, also known as End Stage Kidney Disease (ESKD), which requires dialysis. Urgent action must be taken to address this growing health crisis and ensure those affected by the disease are empowered with the right resources to make informed decisions about treatment options.

The Choose Freedom campaign provides patients with the knowledge and confidence to have meaningful conversations about Peritoneal Dialysis and emphasizes the potential positive impact of Shared Decision Making, a collaborative approach in which patients and their families work with healthcare professionals to choose the dialysis option that works best for their clinical condition, social circumstances, and lifestyle.

Dialysis is the most common form of treatment for CKD patients and involves the removal of waste and excess fluid from the blood when the kidneys are no longer able to fulfil that function well. Peritoneal Dialysis may offer several clinical, quality-of-life, and economic benefits for patients and providers. PD enables patients to maintain their lifestyle and independence while offering potentially better clinical outcomes. PD at home empowers patients to achieve their lifestyle goals and live well while on dialysis.

Dr. Ajay Kher, Medical Director, Epitome Kidney Urology – Delhi, said,” Chronic kidney disease (CKD) in its early phase is asymptomatic and may manifest symptoms very late; it may progress to end-stage kidney disease (ESKD) or renal failure. Patients with chronic kidney disease should discuss with nephrologists their options for dialysis treatment before they progress to end-stage kidney disease (ESKD). This will help them make an informed decision about their course of treatment.”

Dr. Vijay Kher, Chairman of Nephrology, Epitome Kidney Urology Institute said, “Peritoneal Dialysis (PD) is an option for at-home dialysis that carries a decreased risk of infection and can be handled independently by the patient after receiving the necessary training. PD at home empowers patients to achieve their lifestyle goals and live well while on dialysis.”

Rishubh Gupta, General Manager, Baxter India, said, “World Kidney Day is an opportunity to draw attention to Chronic Kidney Disease as well as its management through Peritoneal Dialysis. Baxter is committed to expanding access to PD therapy and enhancing the quality of care for ESKD patients. Our goal is to make PD the initial dialysis therapy of choice by providing smarter patient-centric solutions that enable you to give your patients the best possible care for chronic kidney disease.”